29 cutting-edge medtech innovations recognized with Edison Awards

More than two dozen medical technology developers are winners of the 2023 Edison Awards.

The 29 medtech winners include products from Boston Scientific, Shockwave Medical, Thermo Fisher, DermaSensor and Endiatx. They span four categories: engineering and robotics; health, medical and biotech; manufacturing and logistics; and personal technology and gadgets. Subcategories include smart wearables, noninvasive medtech, advanced drug delivery, AI-assisted medicine, operating room integration and more.

The winners are all finalists for gold, silver and bronze awards. Those awards will be revealed at the Edison Awards Gala on April 20, 2023, in Fort Myers, Florida.

Endiatx co-founder and CEO Torrey Smith with PillBot [Photo by Hardy Wilson for MDO]

Special honors went to Endiatx, which stands by itself as a “game changer” among the approximately 150 Edison Awards winners. Medical Design &…
Read more
  • February 9, 2023
  • 0

FDA authorizes marketing of device to boost tongue muscles and reduce sleep apnea

The FDA announced today that it authorized the marketing of a device for reducing snoring and mild obstructive sleep apnea.

The prescription-only device is used while awake to improve tongue muscle function, which can help prevent the tongue from collapsing backward and obstructing the airway during sleep. It is the first device of this kind used while awake, according to a news release.

Signifier Medical Technologies‘ ExciteOSA device delivers electrical muscle stimulation through a mouthpiece sitting around the tongue. The mouthpiece consists of four electrodes, two above and below the tongue, each. The device’s sessions consist of a series of electrical pulses with rest periods in between, as it is used for 20 minutes once per day during a wakeful state over a six-week period. Then, it is used once per week thereafter.

The FDA observed the ExciteOSA device in 115 patients with snoring, including 48 with snoring and mild sleep apnea. All pa…

Read more
  • February 5, 2021
  • 0